Eton Pharmaceuticals, Inc. Repayments of Related Party Debt
Eton Pharmaceuticals, Inc. (ETON) reported Repayments of Related Party Debt of $2.00 million for the 0-month period ending 2020-08-11, per its 10-K filed 2023-03-16.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfRelatedPartyDebt · last filed 2023-03-16
- 2020-08-11: Repayments of Related Party Debt 0 month $2.00M.
- 2019-11-13: Repayments of Related Party Debt 0 month $2.00M.
| Period end | Repayments of Related Party Debt 0 month |
|---|---|
| 2020-08-11 | $2.00M 10-K · filed 2023-03-16 |
| 2019-11-13 | $2.00M 10-K · filed 2023-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |